Developing and Delivering a Comprehensive Vaccine COVID-19 Program: RapidVax
Author(s) -
Laura A. Siminoff,
Susan VonNessen-Scanlin,
Huanmei Wu,
Briana Richardson,
Patrick J. Kelly,
Sarah Bauerle Bass,
Karikarn Chansiri
Publication year - 2022
Publication title -
commonhealth
Language(s) - English
Resource type - Journals
ISSN - 2690-6910
DOI - 10.15367/ch.v3i1.502
Subject(s) - vaccination , covid-19 , public health , pharmacy , medicine , scale (ratio) , community engagement , family medicine , medical education , nursing , public relations , political science , virology , geography , infectious disease (medical specialty) , disease , cartography , pathology , outbreak
RapidVax was developed in January 2021 to provide COVID-19 vaccination across Temple University’s College of Public Health (CPH). The scale-up phase of the project was an inter-professional effort to develop specific messaging about COVID-19 vaccination and delivered vaccination to communities in Philadelphia, esepcially vaccine-hesitant individuals and marginalized groups with limiteded access to health services. Emphasizing community engagement, evidenced-based message designs, and vaccine delivery, RapidVax has resulted in 1,542 individuals within the CPH and Temple, 2,685 of the general public vaccinated, of which approximately 74.9% were people of color and 16% were homeless (total doses given to date is 7,445). RapidVax, as an interprofessional collaboration between nursing, social work, pharmacy, and public health practitioners, is a promising model to deliver vaccination and decrease disparities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom